Compositions and methods of inhibiting neoplastic diseases...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/35 (2006.01) A61K 31/352 (2006.01)

Patent

CA 2346333

Compositions and methods for the prevention and treatment of neoplastic diseases and atherosclerosis are described. Individuals at a high risk of developing or having neoplasia or atherosclerosis undergoing conventional therapies may be treated with an effective dose of limocitrin compounds including, but not limited to, 3,5,7,4'-tetramethoxylimocitrin, limocitrin 3,5,7,4'-trimethyl ether 5-acetate, 3,5,7,4'-tetramethoxylimocitrin or 3,7,4'- trimethoxylimocitrin, and 5-desmethyl sinensetin.

L'invention concerne des compositions et des procédés de prévention et de traitement de maladies néoplastiques et de l'athérosclérose. Des individus très susceptibles de développer une maladie néoplastique ou l'athérosclérose ou déjà atteints de ces maladies et soumis à un traitement classique peuvent être traités avec une dose effective de composés à base de limocitrine, y compris, entre autres, 3,5,7,4'-tétraméthoxylimocitrine, 3,5,7,4'-triméthyl-éther-5-acétate de limocitrine, 3,5,7,4'-tétraméthoxylimocitrine ou 3,7,4'-triméthoxylimocitrine, et 5-desméthyl-sinensétine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods of inhibiting neoplastic diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods of inhibiting neoplastic diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods of inhibiting neoplastic diseases... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1952162

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.